It can also make it harder to manage blood sugar levels due to insulin resistance
The Biological Reason for Weight Rebound After Stopping When you stop taking semaglutide or tirzepatide, your GLP-1 receptors no longer receive constant activation signals
GLP-1 users exhibited a numerically higher risk for kidney cancer, but the difference did not reach statistical significance (HR = 1.38
GLP-1 users are upping their spending on groceries and clothing
GLP-1 RA glucagon-like peptide 1 receptor agonists, CI confidence interval, MACE major adverse cardiovascular event, MI myocardial infarction, SBP systolic blood pressure in mmHg, HR hazard ratio, RR relative risk, HF heart failure, LVEF left-ventricular ejection fraction a Primary or secondary outcome of interest as reported by the study Statistically significant confidence interval Major Adverse Cardiac Events Among Patients with T2DM Strong evidence supports using GLP-1 RAs to reduce MACE among patients with T2DM and established CVD
